Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

OLMA holding history

Olema Pharmaceuticals, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

OLMA overviewAll 13F holders of OLMAFull Q2 2026 holdings

Shares (Q2 2026)
222,873
Value
$2.79M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of OLMA by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026222,873$2.79M<0.1%−162,188−42.1%ReducedHolders
Q1 2026385,061$5.74M<0.1%+91,501+31.2%AddedHolders
Q4 2025293,560$7.34M<0.1%−897,094−75.3%ReducedHolders
Q3 20251,190,654$11.7M<0.1%−221,445−15.7%ReducedHolders
Q2 20251,412,099$6.02M<0.1%+260,952+22.7%AddedHolders
Q1 20251,151,147$4.33M<0.1%+590,641+105.4%AddedHolders
Q4 2024560,506$3.27M<0.1%+482,959+622.8%AddedHolders
Q3 202477,547$925.9K<0.1%−81,078−51.1%ReducedHolders
Q2 2024158,625$1.72M<0.1%−14,536−8.4%ReducedHolders
Q1 2024173,161$1.96M<0.1%+120,663+229.8%AddedHolders
Q4 202352,498$736.5K<0.1%+38,495+274.9%AddedHolders
Q3 202314,003$172.9K<0.1%+12,493+827.4%AddedHolders
Q2 20231,510$13.6K<0.1%+1,154+324.2%AddedHolders
Q1 2023356$1.24K<0.1%−3,732−91.3%ReducedHolders
Q4 20224,088$10.0K<0.1%+1,657+68.2%AddedHolders
Q3 20222,431$7.00K<0.1%+2,431NewHolders
Q2 20220$00.0%−26−100.0%Sold outHolders
Q1 202226$00.0%−104−80.0%ReducedHolders
Q4 2021130$1.00K<0.1%+130NewHolders
Q2 20210$00.0%−636−100.0%Sold outHolders
Q1 2021636$21.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.